US 12,222,253 B2
Medicament delivery device development evaluation system
Chun Chang, Stockholm (SE); Chia Cheng Lin, Taoyuan (TW); Sheng-wei Lin, Taoyuan (TW); Hsueh-Yi Chen, New Taipei (TW); Yiju Chen, New Taipei (TW); and Wen-Sheng Chien, Taoyuan (TW)
Assigned to SHL MEDICAL AG, Zug (CH)
Appl. No. 17/437,786
Filed by SHL MEDICAL AG, Zug (CH)
PCT Filed Feb. 13, 2020, PCT No. PCT/EP2020/053681
§ 371(c)(1), (2) Date Sep. 9, 2021,
PCT Pub. No. WO2020/182403, PCT Pub. Date Sep. 17, 2020.
Claims priority of application No. 19162434 (EP), filed on Mar. 13, 2019.
Prior Publication US 2022/0155161 A1, May 19, 2022
Int. Cl. G01L 1/22 (2006.01); G01L 5/1627 (2020.01); G01P 15/00 (2006.01)
CPC G01L 1/22 (2013.01) [G01L 5/1627 (2020.01); G01P 15/00 (2013.01)] 19 Claims
OG exemplary drawing
 
1. A medicament delivery device development evaluation system comprising:
a dummy medicament delivery device comprising a plurality of modular units including a main body module and alternative modules, each configured to be detachable to the main body module, wherein each alternative module of the alternative modules differs from a remainder of the alternative modules, and wherein the main body module comprises one or more force sensors configured to detect an external force applied to the dummy medicament delivery device;
processing circuitry configured to receive force measurements from the one or more force sensors, wherein the processing circuitry is configured to compare the force measurements to corresponding reference ranges in order to determine whether the force measurements are within the corresponding reference ranges; and
a storage medium configured to store the force measurements received by the processing circuitry.